V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002546 | 240008567 | 1.66 | 57.6 | null | 2019-04-04 | 2019-04-09 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | AML MYECHILD 01 IT CYT | 100372532 |
| 240002552 | 240008568 | 1.55 | 77.4 | Curative (C) | 2020-09-24 | 2021-01-20 | ETOPOSIDE | 02 | null | ALL ALLR3: S/IR IND | 100131616 |
| 240002555 | 240008570 | 1.67 | 88.5 | Curative (C) | 2021-05-14 | 2021-07-14 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | BUSULFAN | 100371230 |
| 240002557 | 240008572 | 1.71 | 77.75 | Palliative (P) | 2016-06-07 | 2016-06-22 | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 02 | N | RUXOLITINIB | 101559226 |
| 240002559 | 240008573 | 0 | 113.6 | 03 | 2017-11-30 | 2017-12-09 | BUSULFAN | 02 | N | ANAGRELIDE | 100555913 |
| 240002560 | 240008574 | 1.53 | 87.3 | Palliative (P) | 2016-02-25 | 2018-12-06 | FLAG + Idarubicin | 02 | N | IXAZOMIB + LENALIDOMIDE | 100210667 |
| 240002565 | 240008577 | 1.8 | 60 | Curative (C) | 2016-04-28 | 2018-10-12 | null | null | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100932525 |
| 240002569 | 240008579 | null | null | null | null | 2019-02-08 | TRANSPLANT BUSULFAN + FLUDARABINE | null | null | ALL ALLR3: S/IR CONS | 100645679 |
| 240002572 | 240008580 | 0 | 63 | Curative (C) | 2020-02-22 | 2020-02-22 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101846845 |
| 240002576 | 240008582 | 0 | 19.4 | Palliative (P) | 2020-05-08 | 2020-06-16 | AML MyeChild 01 FLA | 02 | N | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100397262 |
| 240002577 | 240008583 | 1.56 | 8.4 | Palliative (P) | 2018-02-18 | 2018-02-24 | null | 02 | null | PEG INTERFERON | 101309020 |
| 240002579 | 240008585 | 1.76 | 73.2 | Curative (C) | null | 2018-12-16 | null | 01 | null | CLADRIBINE | 100466372 |
| 240002585 | 240008589 | 1.82 | 74 | Curative (C) | null | 2019-12-07 | CARMUSTINE + THIOTEPA | N | N | RUXOLITINIB | 101109411 |
| 240002593 | 240008591 | 1.71 | 110.5 | null | 2020-03-28 | 2020-03-30 | FLAIR trial | 02 | null | PEG INTERFERON | 100543603 |
| 240002596 | 240008592 | null | null | null | 2016-06-28 | 2016-06-29 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 02 | null | AML MYECHILD 01 TRIPLE IT | 100426877 |
| 240002597 | 240008593 | 0 | 56.7 | null | 2018-06-12 | 2018-06-17 | AML MyeChild 01 FLA-Idarubicin | Y | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101029319 |
| 240002598 | 240008594 | 1.75 | 15.35 | null | 2018-01-16 | 2018-01-16 | CHOP - 21 days | 02 | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101400535 |
| 240002606 | 240008597 | 1.73 | 86.8 | null | 2016-12-11 | 2016-12-26 | MERCAPTOPURINE + METHOTREXATE | 02 | N | CVP R | 100147441 |
| 240002610 | 240008598 | 1.67 | 70.3 | 03 | 2019-05-20 | 2019-06-16 | DA | N | null | PEG INTERFERON | 100238819 |
| 240002612 | 240008599 | 1.62 | 96 | Adjuvant (A) | 2020-12-18 | 2021-02-02 | GDP | N | N | RUXOLITINIB | 100396553 |
| 240002619 | 240008603 | 1.65 | 84.8 | null | null | 2019-05-15 | ALL UKALL2011 Maintenance A1 | null | null | NOT MATCHED | 101456528 |
| 240002620 | 240008604 | null | 60 | Adjuvant (A) | null | 2020-02-26 | DA 3 + 10 | 01 | null | BUSULFAN | 100852396 |
| 240002621 | 240008605 | 1.67 | 52.1 | null | 2020-12-03 | 2020-12-03 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | Y | RUXOLITINIB | 101627133 |
| 240002624 | 240008606 | null | 84 | null | 2016-10-29 | 2016-12-09 | Cladribine (subcut) 5 days | null | null | TRIAL | 100155741 |
| 240002625 | 240008607 | 1.66 | 17 | Palliative (P) | 2019-06-12 | 2019-09-20 | ALL UKALL2011 Maintenance A1 | N | N | DASATINIB | 101172769 |
| 240002637 | 240008611 | 1.85 | 106.6 | null | 2018-02-01 | 2018-02-02 | null | 02 | null | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 100056675 |
| 240002641 | 240008612 | 1.7 | 54.3 | Curative (C) | 2020-01-16 | 2020-01-18 | null | 02 | N | QUIZARTINIB | 101158486 |
| 240002649 | 240008614 | 1.72 | 74.8 | Disease modification (D) | 2020-11-26 | 2020-12-03 | Imatinib 400mg | 02 | null | BORTEZOMIB | 101317489 |
| 240002653 | 240008616 | 1.6 | 44 | Curative (C) | 2020-01-29 | 2020-02-01 | CISPLATIN + GEMCITABINE | 02 | null | CHOP | 100281202 |
| 240002654 | 240008617 | 1.6 | 52.4 | null | 2018-07-29 | 2018-08-09 | ICE-R | null | null | BORTEZOMIB | 100976932 |
| 240002661 | 240008620 | 1.62 | 77.6 | Disease modification (D) | null | 2019-12-02 | Melphalan IV High dose | null | null | CISPLATIN + CYTARABINE + ETOPOSIDE | 100392129 |
| 240002668 | 240008622 | 1.65 | 52.5 | null | 2016-07-05 | 2016-07-08 | R-EPOCH | 02 | null | RUXOLITINIB | 101535543 |
| 240002674 | 240008623 | 1.63 | 100.5 | null | 2017-12-23 | 2018-06-15 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 101640580 |
| 240002676 | 240008624 | 1.7 | 69.1 | null | 2019-07-02 | 2019-07-11 | Cytarabine High Dose | 02 | null | PEG INTERFERON | 101764303 |
| 240002681 | 240008626 | 1.55 | 90 | null | 2017-03-25 | 2017-03-25 | null | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 101392613 |
| 240002689 | 240008629 | null | 9.2 | null | 2019-09-13 | 2019-09-28 | R-EPOCH | 02 | null | BUSULFAN | 101438199 |
| 240002690 | 240008630 | 1.68 | 13.6 | Curative (C) | 2020-04-28 | 2020-04-28 | null | 02 | N | CAR-T AXICABTAGENE CILOLEUCEL + CYCLOPHOSPHAMIDE + FLUDARABINE | 100728299 |
| 240002697 | 240008632 | 1.75 | 18 | Curative (C) | 2018-05-21 | 2018-07-16 | AML Downs IT Cytarabine | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100451551 |
| 240002698 | 240008633 | 1.73 | 81.7 | Curative (C) | 2019-01-23 | 2019-01-26 | AML Relapsed FLA | 01 | N | AML INTERIM GUIDELINES FLAG-IDA | 100763372 |
| 240002702 | 240008634 | 1.65 | 103 | null | null | 2019-09-16 | PEG INTERFERON | null | null | RUXOLITINIB | 101607922 |
| 240002703 | 240008635 | 1.55 | 55 | null | 2019-11-06 | 2019-11-10 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CNS PNET 5 MEDBL L/STRSK MNT B | 100907534 |
| 240002704 | 240008636 | 1.81 | 96.8 | Curative (C) | 2021-01-22 | 2021-01-22 | RUXOLITINIB | 02 | null | CLADRIBINE | 101247286 |
| 240002706 | 240008637 | 1.77 | 44.8 | Curative (C) | null | 2022-05-29 | null | null | null | ALL UKALL2011 AUG BFM CONS C | 100290092 |
| 240002710 | 240008638 | 1.69 | 77.75 | Curative (C) | 2021-04-20 | 2021-04-21 | Cyclophosphamide High Dose | 02 | null | CYTARABINE HIGH DOSE | 100363568 |
| 240002717 | 240008639 | 1.56 | 99.2 | Palliative (P) | 2017-04-12 | 2017-04-15 | ALL UKALL2011 Cap Int Maint C PAsp | 02 | null | CNS LGG2004 03 VINC + CARBO | 100375542 |
| 240002719 | 240008640 | 1.84 | 81.4 | Curative (C) | 2018-03-08 | 2018-03-17 | CNS Low Grade Glioma Vinblastine | 02 | N | ALL UKALL2011 MAINTENANCE | 101330307 |
| 240002720 | 240008641 | 1.54 | null | 03 | 2018-12-02 | 2018-12-05 | null | null | N | IBRUTINIB | 100130048 |
| 240002722 | 240008642 | 1.82 | 85 | Curative (C) | null | 2018-02-21 | null | null | N | CLADRIBINE | 100415407 |
| 240002723 | 240008643 | null | null | Palliative (P) | 2018-05-09 | 2018-05-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | MUK 9 TRIAL | 100079064 |
| 240002724 | 240008644 | 1.83 | 76.2 | 03 | null | 2017-03-02 | CLADRIBINE | null | N | IBRUTINIB | 101660295 |